Fertility Tech Expansion The company offers kegg, a daily-use vaginal health and fertility tracker with a large early adopter base (80,000 users) and recent Series A funding, signaling readiness for expanded sales, partnerships, and subscription-driven revenue in women’s health.

Growing Funding Recent $6.5M Series A funding alongside existing $11M in total funding indicates strong investor confidence and potential for scale in product development, marketing, and distribution channels.

Direct-to-Consumer Focus With a consumer-facing product and omnichannel tech stack (Shopify, Squarespace, WordPress, Klaviyo, PayPal, Google Ads), there are multiple opportunities to optimize lifecycle marketing, retention programs, and upsell of complementary health tools.

Healthcare Data Potential The proprietary vaginal health platform collects unique data on cervical mucus and fertility windows, creating opportunities for partnerships with clinics, telehealth providers, and research collaborations and potential data-driven product extensions.

Market Positioning As a niche femtech player with competitive differentiators around daily vaginal insertion and data collection, there is room to position for strategic B2B collaborations (brands, insurers, healthcare providers) and cross-sell to adjacent personal care categories.